Novel biological markers for the diagnosis and prediction of mortality risk in patients with pulmonary embolism
Pulmonary embolism (PE) ranks third in the structure of death causes among all cardiovascular diseases after myocardial infarction and stroke. That is why the timely and earliest possible diagnosis of venous thromboembolism is of particular importance, which will help improve both short-term and lon...
Main Authors: | A. A. Podlipaeva, I. S. Mullova, T. V. Pavlova, E. V. Ushakova, D. V. Duplyakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2021-01-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4202 |
Similar Items
-
Russian register of acute pulmonary embolism SIRENA: characteristics of patients and in-hospital treatment
by: A. D. Erlikh, et al.
Published: (2020-11-01) -
Clomiphene- induced pulmonary embolism
by: Chahat Puri, et al.
Published: (2021-03-01) -
Pulmonary Embolism: Diagnosis and Treatment
by: Ewa Piasek, et al.
Published: (2019-09-01) -
Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation
by: Carmen Fernández‐Capitán, et al.
Published: (2021-01-01) -
Asymptomatic pulmonary embolism in patients with symptomatic deep vein thrombosis of the extremities: Three year results of a prospective study
by: Stavros Kerasidis, et al.
Published: (2016-09-01)